We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site you are agreeing to our use of cookies. If you would like to know more please click here.

Latest News

HitGen and Cyclofluidic Collaborate on Lead Development Programme


HitGen Ltd today announced that it has entered into research collaboration with Cyclofluidic Ltd, UK, using hits obtained from HitGen’s proprietary lead discovery technology. Within the framework of the collaboration, novel allosteric inhibitors of GSK3b, a kinase implicated in neurodegenerative diseases, will be optimised using CyclOpsTM technology to provide advanced leads suitable for clinical development.

Posted by author Date 17/04/2015